Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Press Releases | February 26, 2024 | Cuttsy + Cuttsy

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Rare, But Out There: The art of reaching rare disease patients through understanding human experience

White Papers and Resources | February 26, 2024 | Havas Life London

Director Helena Wright talks about the importance of understanding the beliefs, emotional drivers and cultural factors that underpin the experience of living with a rare disease, as we mark Rare...

Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes

Press Releases | February 21, 2024 | Graphite Digital

Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.

THE SECRET TO EFFECTIVE IMPACT MEASUREMENT IN DIGITAL MEDICAL EDUCATION

Press Releases | February 21, 2024 | EPG Health

Moving away from 'vanity' metrics towards demonstrating real value for healthcare professionals and their patients, the time is right to evolve impact measurement in digital medical education.

Enhancing the patient–HCP relationship in rare diseases

White Papers and Resources | February 21, 2024 | Amiculum

By Maggie Lai

The evolving healthcare advertising landscape

White Papers and Resources | February 20, 2024 | Wiley

Industry experts share their insights on the emerging trends in healthcare advertising

Clinical trial considerations: Why supporting HCPs matters…

White Papers and Resources | February 20, 2024 | Cuttsy + Cuttsy

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

How we’re making AI a part of life at 11 London

Press Releases | February 20, 2024 | 11 London

This article talks about how AI is being used more in advertising, showing how it can change the way things are done from planning out strategies to coming up with...

Shortening the Journey at the Unusual Suspects Meeting

Press Releases | February 19, 2024 | Medscape Education

Medscape will be continuing their mission to shorten the diagnostic journey for patients with a rare disease at this year’s Unusual Suspects event on February 21.The Unusual Suspects is an...

Whitepaper: Enhancing the value of HCP education through independent channels

White Papers and Resources | February 19, 2024 | Wiley

Download our whitepaper to discover best practices from industry experts for providing independent medical education (IME) to healthcare professionals.